United States · 
Who invested in Two Chairs?
Two Chairs's investors include Amplo, Maveron and Goldcrest Capital.
20202021202220232024
$21MSeries B$72MSeries C
United States · Series C startup
Who invested in Two Chairs
Funding summaryUpdated 26 Oct 2026
$93Mraised across 2 rounds since 2019, from 2 sources
$21MSeries B$72MSeries C
- Latest round
- Series C, $72MApr 2024
- Step-upi
- 3.4×
- Investors
- 3 (1 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $21M Aug 2019
- Biggest round
- $72M Series C · Apr 2024
- Between rounds
- 4.7 years from the last two
The rounds
- Apr 2024
- Aug 2019
Founders and team
From Two Chairs's own website: 1 founder, 5 on the team.
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Two Chairs as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Two Chairs
How much has Two Chairs raised?
Two Chairs has raised $93M across 2 rounds since 2019.
When did Two Chairs last raise?
Two Chairs's most recent round was a Series C of $72M in Apr 2024.
What was Two Chairs's biggest round?
Its most recent round, $72M in Apr 2024, is also its largest on record.
Who backed Two Chairs first?
Two Chairs's first round on record, in Aug 2019, was backed by Amplo, Maveron and Goldcrest Capital.
What stage is Two Chairs at?
Two Chairs's latest named round is a Series C, in Apr 2024.
Where is Two Chairs based?
Two Chairs is based in the United States.
Who led Two Chairs's rounds?
Amplo led the Series B in 2019.
Companies like Two Chairs
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.